INTEGRATED BIOPHARMA, INC. (INBP) Operating cash flow 2017–2026
INTEGRATED BIOPHARMA, INC. (INBP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$1.2MFY2026 · since FY2017: $397,000 → $1.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $1.2M | -39.9% |
| FY2025 | $2.1M | +119.0% |
| FY2024 | $943,000 | -23.5% |
| FY2023 | $1.2M | -69.9% |
| FY2022 | $4.1M | +34.1% |
| FY2021 | $3.0M | +127.8% |
| FY2020 | $1.3M | +308.2% |
| FY2019 | $328,000 | -71.9% |
| FY2018 | $1.2M | +194.2% |
| FY2017 | $397,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INBP financial trends
INBP RevenueINBP Net incomeINBP Net marginINBP Gross profitINBP Gross marginINBP Operating incomeINBP Operating marginINBP Free cash flowINBP Capital expendituresINBP Return on equityINBP Stock buybacksINBP Dividends paidINBP Total assetsINBP Total liabilitiesINBP Shareholders’ equityINBP overview →